N-Acetylserotonin in the Central Nervous System
Overview
Affiliations
N-acetylserotonin has been identified by immunohistochemistry in specific brain areas separate from melatonin and serotonin. N-acetylserotonin is widely distributed within the brain stem, cerebellum and hippocampus and in the brain stem it is contained within the reticular formation nuclei and motor nuclei. Like serotonin, N-acetylserotonin appears to be derived from tryptophan as tryptophan hydroxylase inhibition leads to a lowering in immunoreactive N-acetylserotonin in brain and blood. Beta adrenergic drugs influence N-acetylserotonin neurons with beta adrenergic agonists causing a rise in immunoreactive N-acetylserotonin. The presence of N-acetylserotonin in brain has been confirmed by gas chromatography, mass spectrometry and radioimmunoassay. At this point little is known of the possible role of N-acetylserotonin in the brain. In the hippocampus N-acetylserotonin is present in granule cells and its appearance parallels the appearance of those cells. High affinity binding of tritiated N-acetylserotonin is found in brain and in various brain areas and this radioligand appears to label serotonergic receptors. Preliminary iontophoretic studies performed on hippocampal slices indicate an inhibitory action of N-acetylserotonin on glutamate induced firing of pyramidal cells. Taken together these findings suggest that N-acetylserotonin may have a role in the central nervous system distinct from that of being a precursor for melatonin. If this hypothesis is correct it would suggest that indoleamines have certain similarities to catecholamines. Thus for the catecholamines, dopamine, norepinephrine and epinephrine form a synthetic sequence and yet have independent roles as neurotransmitters and/or hormones. The three indoleamines serotonin, N-acetylserotonin and melatonin also form a synthetic sequence and these three substances may also have independent roles as neurotransmitters and/or hormones.
Identification of a serotonin N-acetyltransferase from ED99.
Hafza N, Li N, Luqman A, Gotz F Front Microbiol. 2023; 14:1073539.
PMID: 36910235 PMC: 9992809. DOI: 10.3389/fmicb.2023.1073539.
Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice.
Yu S, Zheng J, Jiang Z, Shi C, Li J, Du X Int J Mol Sci. 2013; 14(9):17680-93.
PMID: 23994834 PMC: 3794748. DOI: 10.3390/ijms140917680.
Serotonin-kynurenine hypothesis of depression: historical overview and recent developments.
Oxenkrug G Curr Drug Targets. 2013; 14(5):514-21.
PMID: 23514379 PMC: 3726541. DOI: 10.2174/1389450111314050002.
N-acetylserotonin and aging-associated cognitive impairment and depression.
Oxenkrug G, Ratner R Aging Dis. 2012; 3(4):330-8.
PMID: 23185714 PMC: 3501368.
Polymorphisms in melatonin synthesis pathways: possible influences on depression.
Kripke D, Nievergelt C, Tranah G, Murray S, McCarthy M, Rex K J Circadian Rhythms. 2011; 9:8.
PMID: 21827647 PMC: 3177871. DOI: 10.1186/1740-3391-9-8.